The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.

Samankaltaisia teoksia

• The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis
  Tekijä: Clark, W, et al.
  Julkaistu: (2004)
• The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.
  Tekijä: Clark, W, et al.
  Julkaistu: (2004)
• The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis
  Tekijä: W Clark, et al.
  Julkaistu: (2004-09-01)
• A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
  Tekijä: Chen, Y, et al.
  Julkaistu: (2006)
• A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
  Tekijä: Chen, Y, et al.
  Julkaistu: (2006)